2023 - Research.com Immunology in United Kingdom Leader Award
2000 - Fellow of the Royal Society of Edinburgh
Christopher Haslett focuses on Immunology, Inflammation, Apoptosis, Cell biology and Granulocyte. His Immunology research integrates issues from Cancer research, Macrophage, Pharmacology and Lung. His Inflammation research is multidisciplinary, relying on both Anti inflammatories, Phagocytosis and Neuroscience.
Christopher Haslett is involved in the study of Apoptosis that focuses on Programmed cell death in particular. His work deals with themes such as Cell adhesion and Doxorubicin, which intersect with Cell biology. The concepts of his Granulocyte study are interwoven with issues in Necrosis, Lipopolysaccharide and Tumor necrosis factor alpha.
His primary areas of study are Immunology, Inflammation, Apoptosis, Cell biology and Cancer research. His Immunology research includes themes of Bronchoalveolar lavage and Lung. His research investigates the connection between Lung and topics such as Bleomycin that intersect with issues in Pathology.
His Inflammation research is multidisciplinary, incorporating elements of Necrosis, Innate immune system, Phagocytosis and Macrophage. His work in Apoptosis addresses issues such as Molecular biology, which are connected to fields such as Lipopolysaccharide and Chemotaxis. His research in Cell biology tackles topics such as Integrin which are related to areas like Integrin alpha M.
His primary scientific interests are in Inflammation, Immunology, In vitro, Bronchoalveolar lavage and Lung. The Inflammation study combines topics in areas such as Phagocytosis, ARDS, Immune system and Apoptotic cell clearance. The various areas that Christopher Haslett examines in his Immunology study include Formyl peptide receptor 1 and Apoptosis.
His study looks at the relationship between Apoptosis and topics such as Kinase, which overlap with Cyclin-dependent kinase. His study in Bronchoalveolar lavage is interdisciplinary in nature, drawing from both Antimicrobial, Microbiology, Granulocyte, Immunopathology and Histamine. His research integrates issues of Cancer research and Histology in his study of Lung.
Christopher Haslett mostly deals with Immunology, Inflammation, Bronchoalveolar lavage, Fluorophore and Apoptosis. His studies deal with areas such as Formyl peptide receptor 1 and Chemotaxis as well as Immunology. His Chemotaxis research incorporates elements of Disease, Function and Pathogenesis.
His Bronchoalveolar lavage study incorporates themes from Immune system, Granulocyte, Immunopathology and Histamine. His work on Caspase as part of general Apoptosis study is frequently linked to Wogonin, therefore connecting diverse disciplines of science. Christopher Haslett has researched Caspase in several fields, including Eosinophil, Phagocytosis, Anti-inflammatory, Respiratory infection and Allergic inflammation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.
John S Savill;Andrew H. Wyllie;Janet E Henson;Mark J Walport.
Journal of Clinical Investigation (1989)
A blast from the past: clearance of apoptotic cells regulates immune responses
John Savill;Ian Dransfield;Chris Gregory;Chris Haslett.
Nature Reviews Immunology (2002)
Phagocyte recognition of cells undergoing apoptosis
John Savill;Valerie Fadok;Peter Henson;Chris Haslett.
Immunology Today (1993)
Resolution of inflammation: state of the art, definitions and terms.
Charles N. Serhan;Sue D. Brain;Christopher D. Buckley;Derek W. Gilroy.
The FASEB Journal (2006)
Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.
John Savill;Nancy Hogg;Yi Ren;Christopher Haslett.
Journal of Clinical Investigation (1992)
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.
Christopher Haslett;L A Guthrie;M M Kopaniak;R B Johnston Jr.
American Journal of Pathology (1985)
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
Tariq Sethi;Robert C. Rintoul;Sarah M. Moore;Alison C. MacKinnon.
Nature Medicine (1999)
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
S. C. Donnelly;C. Haslett;Robert M. Strieter;Steven L. Kunkel.
The Lancet (1993)
Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.
Alison Lee;Moira K.B. Whyte;Christopher Haslett.
Journal of Leukocyte Biology (1993)
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.
L C Meagher;J M Cousin;Jonathan Seckl;Christopher Haslett.
Journal of Immunology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: